P. Labarre

发表

Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.

E. Hindié, A. Veyre, N. Moins, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Secondary Ion Mass Spectrometry as a Tool for Investigating Radiopharmaceutical Distribution at the Cellular Level: The Example of I-BZA and 14C-I-BZA

E. Hindié, A. Veyre, N. Moins, 2005 .

123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging

A. Veyre, N. Moins, J. Papon, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Internal dosimetry through GATE simulations of preclinical radiotherapy using a melanin-targeting ligand

N. Moins, J. Papon, J. Chezal, 2014, Physics in medicine and biology.

Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.

J. Maublant, C. Lartigue, N. Moins, 2008, Bioorganic & medicinal chemistry.

Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.

J. Boire, A. Veyre, J. Papon, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent

A. Veyre, N. Moins, J. Papon, 2002, Melanoma research.

Radiation dosimetry of [131I]ICF01012 in rabbits: Application to targeted radionuclide therapy for human melanoma treatment

J. Chezal, E. Miot-Noirault, L. Maigne, 2018, Medical physics.

Evaluation of two 125I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma

N. Moins, J. Papon, J. Chezal, 2014, Investigational New Drugs.

Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter

N. Moins, J. Papon, J. Madelmont, 2011, Investigational New Drugs.

Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients.

J. Madelmont, J. Armand, C. Marchenay, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences

J. Papon, J. Madelmont, A. Croisy, 2004, Biomedical engineering online.

Qualitative and quantitative analysis of a new sulphur-containing nitrosourea in blood by high-performance liquid chromatography.

A. Veyre, J. Madelmont, G. Mathé, 1987, Journal of chromatography.

Disposition of new sulphur-containing 2-(chloroethyl)nitrosoureas in rats.

J. Madelmont, P. Labarre, R. Plagne, 1987, Xenobiotica; the fate of foreign compounds in biological systems.

Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.

N. Moins, J. Papon, J. Madelmont, 2008, Nuclear medicine and biology.

Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.

J. Maublant, C. Lartigue, N. Moins, 2008, Journal of medicinal chemistry.

Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents.

A. Veyre, N. Moins, J. Papon, 2001, Nuclear medicine and biology.

Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting

A. Veyre, N. Moins, J. Papon, 1999, European Journal of Nuclear Medicine.

Marquage par 14C du Chloro‐2 Ethyl Isocyanate. Application au Marquage de Chloroethyl Tetrazinone et de Chloroethylnitrosourees

A. Veyre, J. Madelmont, M. Moreau, 1988 .

The use of [(125)I] scintigraphic in vivo imaging in melanoma-bearing mice for a rapid prescreening of vectors to melanoma tissue.

J. Maublant, N. Moins, J. Papon, 2009, Cancer biotherapy & radiopharmaceuticals.

A New O6-Alkylguanine-DNA Alkyltransferase Inhibitor Associated with a Nitrosourea (Cystemustine) Validates a Strategy of Melanoma-Targeted Therapy in Murine B16 and Human-Resistant M4Beu Melanoma Xenograft Models

J. Papon, J. Madelmont, A. Croisy, 2008, Journal of Pharmacology and Experimental Therapeutics.

Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.

J. Boire, N. Moins, J. Papon, 1995, Nuclear medicine and biology.

Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.

A. Veyre, N. Moins, J. Papon, 2005, Nuclear medicine and biology.

Promising pre-clinical validation of targeted radionuclide therapy using a [131I] labelled iodoquinoxaline derivative for an effective melanoma treatment

Frédérique Penault-Llorca, F. Penault-Llorca, N. Moins, 2009 .

Targeted radionuclide therapy of melanoma: Anti‐tumoural efficacy studies of a new 131I labelled potential agent

J. Maublant, F. Penault-Llorca, N. Moins, 2009, International journal of cancer.

Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent.

N. Moins, J. Papon, J. Madelmont, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.

J. Papon, J. Madelmont, P. Labarre, 2008, Journal of medicinal chemistry.

Synthesis of three no-carrier-added O6-4-[125I] iodobenzylguanosine derivatives, new reagents for the assay of O6-alkylguanine-DNA alkyltransferase activity

A. Veyre, J. Madelmont, M. Moreau, 1995 .

Study of implanted biomaterial functionality by diphosphonate molecules labeled with radioactive99mTc

J. Madelmont, P. Labarre, J. Bonafous, 2007, Biological Trace Element Research.

Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.

N. Moins, J. Papon, J. Madelmont, 2005, Nuclear medicine and biology.

Brain uptake of labelled adiphenine in rats.

A. Veyre, M. Moreau, P. Labarre, 1986, Biopharmaceutics & drug disposition.

Adiphenine plasma levels and blood-brain barrier crossing in the rat

A. Veyre, M. Moreau, P. Labarre, 1985, European journal of drug metabolism and pharmacokinetics.

Tissue distribution and metabolism in rat of an ethynesulphonamide with filaricidal activity.

A. Veyre, J. Madelmont, P. Gayral, 1997, Xenobiotica; the fate of foreign compounds in biological systems.

Determination of adiphenine, diphenylacetic acid and diethylamino-ethanol by high-performance liquid chromatography.

J. Madelmont, M. Moreau, P. Labarre, 1983, Journal of chromatography.

Metabolism of adiphenine. II. Identification of major excretion metabolites in rats.

J. Madelmont, P. Labarre, J. Michelot, 1982, Xenobiotica; the fate of foreign compounds in biological systems.

P29 New heteroaromatic compounds for a targeted melanoma therapy: factors modulating subcellular distribution

N. Moins, J. Papon, J. Madelmont, 2010 .

Pharmacokinetics of Two New 2-Chloroethylnitrosoureas in Cancer Patients Submitted to Phase II Clinical Trials

A. Veyre, J. Madelmont, P. Chollet, 1994 .

Radiosynthesis of no-carrier-added N-(4-dipropyl aminobutyl)-4-[125I]-iodobenzamide, a promising tracer for the detection of melanoma

J. Papon, J. Madelmont, M. Moreau, 1998 .